| scholarly article | Q13442814 |
| P2093 | author name string | Mei Yue | |
| Keith M Olsen | |||
| Laurel C Preheim | |||
| Mary U Snitily | |||
| Martha Gentry-Nielsen | |||
| P2860 | cites work | Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention | Q28201389 |
| Maintaining fluoroquinolone class efficacy: review of influencing factors | Q30310427 | ||
| Moxifloxacin | Q33588540 | ||
| A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'. | Q33670442 | ||
| Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci | Q33976055 | ||
| Application of fluoroquinolone pharmacodynamics | Q34076026 | ||
| Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus | Q34107094 | ||
| Evaluation of the clinical microbiology profile of moxifloxacin | Q34183540 | ||
| Moxifloxacin: clinical efficacy and safety | Q34189561 | ||
| Clinical role of protein binding of quinolones | Q34774058 | ||
| Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys | Q35122822 | ||
| Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses | Q35129323 | ||
| Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae | Q35133005 | ||
| Pulmonary disposition of antimicrobial agents: methodological considerations | Q35447413 | ||
| In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria | Q35809411 | ||
| Hepatic, metabolic and toxic effects of ethanol: 1991 update | Q37414939 | ||
| Cellular iron metabolism in health and disease | Q37783194 | ||
| Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults | Q37868241 | ||
| Activation of the oxidative metabolism in human polymorphonuclear neutrophilic granulocytes: the role of immuno-modulating cytokines | Q38010176 | ||
| Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia | Q39651829 | ||
| Pharmacodynamics of a Novel Des-F(6)-Quinolone, BMS-284756, against Streptococcus pneumoniae in the Thigh Infection Model | Q39746333 | ||
| Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae | Q39784239 | ||
| Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy | Q40390211 | ||
| The chemistry and biological profile of trovafloxacin | Q41530540 | ||
| Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models | Q42169493 | ||
| Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults | Q42621706 | ||
| Effects of granulocyte colony-stimulating factor in cirrhotic rats with pneumococcal pneumonia | Q43612345 | ||
| Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. | Q44037186 | ||
| Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography | Q44108067 | ||
| Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia | Q44257279 | ||
| An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome | Q44510164 | ||
| Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy | Q44511523 | ||
| High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm | Q44573499 | ||
| Levofloxacin and trovafloxacin inhibition of experimental fracture-healing | Q44579509 | ||
| Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia | Q45255735 | ||
| Alcohol research in the Veterans Administration: a success story | Q45336532 | ||
| Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography | Q47882319 | ||
| Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats | Q48177410 | ||
| Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. Austrian Bacterial Surveillance Network. | Q54090934 | ||
| Effect of cirrhosis on the production and efficacy of pneumococcal capsular antibody in a rat model. | Q54260950 | ||
| Pulmonary recruitment, adherence, and chemotaxis of neutrophils in a rat model of cirrhosis and pneumococcal pneumonia | Q68064107 | ||
| Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae | Q68176345 | ||
| A simple method for collection of blood from the rat foot | Q68261885 | ||
| Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution | Q68861405 | ||
| Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations with the filter method | Q70231763 | ||
| Determination of trovafloxacin, a new quinolone antibiotic, in biological samples by reversed-phase high-performance liquid chromatography | Q71088303 | ||
| Failure of intensive care unit support to influence mortality from pneumococcal bacteremia | Q71655334 | ||
| The effect of ethanol ingestion on killing of Streptococcus pneumoniae, Staphylococcus aureus and Staphylococcus epidermidis by rat neutrophils | Q71710865 | ||
| Ethanol ingestion impairs neutrophil bactericidal mechanisms against Streptococcus pneumoniae | Q71951872 | ||
| Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet | Q72213153 | ||
| Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin | Q73508354 | ||
| Comparative in vivo activity of gemifloxacin in a rat model of respiratory tract infection | Q73819635 | ||
| Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction | Q74059513 | ||
| Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America | Q74315684 | ||
| Community-acquired pneumonia | Q75190399 | ||
| Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia | Q77889875 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| P304 | page(s) | 210-219 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia | |
| P478 | volume | 50 |
| Q37914449 | Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses |
| Q37293669 | Animal models of Streptococcus pneumoniae disease |
| Q37867260 | Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients |
| Q94528468 | Investigating the effect of some fluoroquinolones on C-reactive protein levels and ACh-Induced blood pressure reduction deviations after aging of diabetes in STZ-Induced diabetic wistar rats |
| Q41262080 | Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model |
Search more.